|
Business Advisory Board
The Ceres Business Advisory Board provides business advice and support to the management of Ceres. The Board members act in a business advisory capacity and as enablers for business development and industry networking. The Board consists of six sitting members appointed by the Ceres management team and meets four times per year. Additionally, the Ceres management team and Board members maintain a constant dialogue outside of the formal meetings to collaborate on various initiatives and projects.
Jerry Coughter
Stephen Danielson
James DeOlden
Robin A. Felder, Ph.D.
Jennifer Murphy
Klaus Schafer, MD, MPH
Terry Sharrer, Ph.D.
Jerry Coughter
Business Advisory Board
Mr. Coughter is the Campus Executive Officer for George Mason University in Loudoun County, Virginia. He previously served as Executive Director of Governor Warner's Biotechnology Commission and was the Industry Director for Biotechnology at Virginia's Center for Innovative Technology, leading the Commonwealth's efforts to grow the industry state-wide. He is a frequent speaker on the roles of universities and state governments in growing technology sectors, including University-centered economic development and innovative models for funding commercialization of new technologies by small businesses. Mr. Coughter has served on SBIR review panels for NSF. He earned a BS in molecular biology at Clemson University, an MS in microbiology & immunology from the Medical College of Virginia Commonwealth University, and an MBA from the Byrd School of Business at Shenandoah University
|
Stephen Danielson
Business Advisory Board
Mr. Danielson is a Senior Director, Regulatory Affairs with MedImmune LLC, the biologics unit of AstraZeneca, and has ten years of Regulatory experience in small molecules, biologics and devices. His team shares global regulatory responsibility for the investigational drugs in MedImmune's inflammation, autoimmune and infectious diseases portfolios, all of which are monoclonal antibodies. The portion of the portfolio for which Steve and his team are responsible includes one marketed product, approved and marketed in 62 countries, and several other programs in early and later stages of development, primarily in the autoimmune area. Mr. Danielson holds a B.S. in Organic Chemistry from the Illinois Institute of Technology.
|
James DeOlden
Business Advisory Board
Mr. DeOlden is the president, CEO and founder of Mediatech Inc., a leading manufacturer of life science products for academic and government research institutions, and pharmaceutical corporations. The company employs 150 people, and was named "Biotechnology Company of the Year" in 2004 by the Virginia Biotechnology Association. Mr. DeOlden obtained a B.S. in Microbiology and an M.S. in Biochemistry from CSULB, as well as an MBA from the University of Maryland. He also serves as a board member of the Virginia Biotechnology Association.
|
Robin A. Felder, Ph.D.
Business Advisory Board
Dr. Felder is a Professor of Pathology, Associate Director of Clinical Chemistry at the University of Virginia, as well as Former Director of the Medical Automation Research Center. He received his doctorate from Georgetown University, and continued his post-doctoral training with The National Institutes of Health (NIH) in Bethesda, MD. He conducts basic, clinical and applied research ranging from medical robotics to human hypertension. Dr Felder has spun out 8 companies from the University of Virginia including Medical Automation Systems, Hypogen, WellAWARE Systems, Global Cell Solutions, Ibetics, the Association for Laboratory Automation, and Medical Automation.org.
|
Jennifer Murphy
Business Advisory Board
Jennifer Murphy is the Assistant Vice President for Research and Economic Development and Director of Technology Transfer at George Mason University. She is also the Executive Director of George Mason Intellectual Properties, Inc. (GMIP). Ms. Murphy has been with George Mason for 21 years, 12 of which were as Director of the Office of Sponsored Programs. Prior to joining George Mason University, Ms. Murphy held positions in university administration and sponsored programs at The American University in Washington, D.C. and at Gallaudet University. Ms. Murphy attended the University of Maryland and American University at the undergraduate level and received her MBA from American University in 1982. Ms. Murphy has been a business reviewer for the Civilian Research Defense Fund (CRDF) "Next Steps" program. Ms. Murphy has been actively engaged in a number of professional organizations, in particular the National Grants Management Association (NGMA), The Association of University Technology Managers (AUTM), the Licensing Executive Society (LES), and the Academic Licensing Community of Virginia (ALCOVe).
|
Klaus Schafer, MD, MPH
Business Advisory Board
Dr. Shafer is the President and CEO of TessAraeŽ, a limited liability company founded to develop and commercialize comprehensive differential diagnostic genomic based technology for the detection of infectious disease agents. The company is also helping the industry by developing resequencing tools for more rapid mutation detection in various diseases. Dr. Schafer has previously held positions in the Department of Defense as the Asst. to the Secretary of Defense for Chemical and Biological Defense and as the former Asst. Surgeon General for the U.S. Air Force, where he organized and oversaw the Surgeon General's technology program.
|
Terry Sharrer, Ph.D.
Business Advisory Board
Mr. Sharrer is the director of Innovative Health at INOVA Hospital. He previously held the position of Curator of Health Sciences at the National Museum of American History, Smithsonian Institution, where he worked for 37 years. He received a Ph.D. in history from the University of Maryland, and is the author of three dozen publications about a range of life science subjects. He has been heavily involved in public service, including serving on the boards of the Carillion Biomedical Institute in Roanoke, VA, Immune Deficiency Foundation in Towson, MD, and Inova Fairfax Hospital Cancer Advisory Committee in Fairfax, VA, as well as serving as Chairman of the Board of Directors of the National Foundation for Cancer Research in Bethesda, MD.
|
|
